Abstract: The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).

Abstract: A HBS-specific antibody, a LHBS-specific antibody, a WT LHBS-specific antibody, an immunoassay kit comprising the antibodies, and a method of detecting pre-S2 deletion mutant LHBS using the immunoassay kit are disclosed herein. The method comprises incubating a biological sample with a first antibody to captured HBS proteins; detecting the LHBS and WT LHBS bound to the immobilized first antibody, respectively; and calculating the amount of the pre-S2 deletion mutant LHBS protein by subtracting the amount of the WT LHBS protein from that of the LHBS protein. Advantageously, by the method described herein, the amount of the pre-S2 deletion mutant LHBS, a potential high-risk marker for HCC incidence in chronic HBV carriers and recurrence in HCC patients after hepatectomy surgery, in a biological sample may be easily calculated without mutual influence between the WT and pre-S mutant LHBS while reducing the labor-intensive process for cloning each gene product before analysis.

Abstract: The present disclosure relates, in general, to materials and methods for antibodies specific for transforming growth factor beta (TGF?), including TGF?1, TGF?2 and TGF?3, and uses of these antibodies in the treatment of subjects having cancer, an eye disease, condition or disorder, fibrosis, including ophthalmic fibrosis or fibrosis of the eye, and other conditions or disorders related to TGF? expression.

Abstract: For determining the presence and amount of human interleukin 3 (IL-3) in a sample, the present invention provides a diagnostic method, wherein an anti-IL-3-antibody, fragment or construct thereof is added to said sample under conditions which allow for binding said antibody, fragment or construct thereof to IL-3 and detecting the amount of antibody bound IL-3 in said sample, wherein the anti-IL-3-antibody is clone 13. Further subject matter of the present invention are the novel antibody clone 13, a nucleic acid encoding said antibody and a hybridoma cell line which produces antibody clone 13. A diagnostic assay kit contains all necessary reagents and materials for performing such assay, preferably an ELISA assay and especially preferably contains antibody clones 13 and 11.

Abstract: An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: The present disclosure provides compounds comprising modified oligonucleotides and anti-CD22 antibodies. Certain such modified oligonucleotides conjugated to anti-CD22 antibodies are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.

Abstract: The present invention is directed to anti-PVRIG antibodies and methods of using same.

Abstract: The invention provides an anti-CTLA4 antibody which inhibits the binding of CTLA4 to human B7, in particular, it inhibits binding of CTLA4 to human B7.1 and/or human B7.2. Specific antibodies are provided with specific variable region sequences as well as compositions comprising such antibodies for use in treating disease.

Abstract: According to the present invention, a heterodimer protein composition that is composed of a first polypeptide comprising an immunoglobulin heavy chain constant region and a second polypeptide comprising CL-Fc prepared by fusion of an immunoglobulin light chain constant region (CL) and Fc region, and also has a deletion or substitution of Cys residues involved in disulfide bonds between CL and CH1, a purification method of the protein composition thereof, a preparation method of the protein composition thereof, a DNA and a vector encoding the protein composition thereof are provided.

Abstract: The present invention relates to Bispecific antibodies against human TWEAK and human IL17 (bispecific TWEAK-IL17 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Abstract: The present invention relates generally to glutamine-free cell culture media supplemented with asparagine. The invention further concerns the production of recombinant proteins, such as antibodies, in asparagine-supplemented glutamine-free mammalian cell culture.

Abstract: Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Abstract: The present invention relates to antibodies and their fragments that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies and their immunoreactive fragments that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.

Abstract: The present invention relates to antibodies and their fragments that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies and their immunoreactive fragments that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.

Abstract: Isolated human monoclonal antibodies which bind to human TF and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies.

Abstract: The present invention provides an antibody which binds to a fibroblast growth factor receptor.

Abstract: There is disclosed a method for processing a biomass (for example straw) containing lignocellulose such that cellulose and hemicellulose are made accessible for further processing, typically by decomposition, without needing energy-consuming dissolution of the biomass in water. The method includes repeated compressions of the biomass in a reciprocating piston press, where loose biomass is continuously fed into a piston chamber in front of a piston which moves the loose biomass into a tubular reaction chamber in which the biomass is compressed for producing a vapor explosion and autohydrolysis under simultaneous displacement of compressed biomass through the reaction chamber. After compression, to the biomass can be added fluid livestock manure, fluid waste water sludge etc. in a biogas plant for subsequent biogas processing.

Abstract: The invention relates to continuous polymerization apparatus comprising a tubular reactor with a continuous loop section (32), a secondary line section (33) and a pigging system (39) that allows for cleaning of both sections of the reactor in a single continuous pass without manual removal of the pig.

Abstract: Disclosed is a method for selectively hydrogenating a copolymer, including contacting a heterogeneous catalyst with a copolymer to process hydrogenation. The copolymer includes aromatic rings and double bonds, and the double bonds are hydrogenated, and the aromatic rings are substantially not hydrogenated. The heterogeneous catalyst includes a metal catalyst such as platinum, palladium, platinum-iridium alloy, or platinum-rhenium alloy formed on a porous support. The hydrogenation is processed at a temperature of 40° C. to 150° C. under a hydrogen pressure of 10 kg/cm2 to 50 kg/cm2.

Abstract: A method of making a solid catalyst component for production of a polyolefin, including the steps of: a) dissolving a halide-containing magnesium compound in a mixture including alkylepoxide, an organic phosphorous compound, a carboxylic acid or anhydride, and a hydrocarbon solvent to form a homogenous solution; b) optionally treating the homogeneous solution with a halogenating agent; c) treating the homogenous solution with a first titanium halide compound in the presence of a surface modifier and optionally a first electron donor to form a solid precipitate, wherein, if present, the first electron donor is an ether; d) optionally treating the solid precipitate with a second electron donor; and e) treating the solid precipitate with a second titanium halide compound and optionally with a second electron donor to form the solid catalyst component.

Abstract: A solid catalyst component for the polymerization of olefins comprising Mg, Ti, Cl and at least an electron donor compound which is the reaction product obtained by bringing into contact a Mg compound and a Ti compound having at least a Ti-halogen bond with an electron donor selected from specific diphenol derivatives.

Abstract: A process for producing a copolymer involves contacting at least one isoolefin monomer with at least one multiolefin and/or ?-pinene monomer in the presence of at least one Lewis acid and at least one initiator in a diluent. The diluent contains a hydrofluorinated olefin (HFO) comprising a tetrafluorinated propene. Copolymers produced by a process of the present invention have a cyclic oligomer content lower than comparable polymers produced in a butyl rubber slurry process using 1,1,1,2-tetrafluoroethane and/or methyl chloride as a diluent as well as a more favorable ratio of C21/C13. Hydrofluorinated olefins used in the present invention are better diluents for butyl slurry cationic polymerization than saturated hydro fluorocarbons.

Abstract: Catalyst systems and methods for making and using the same are described herein. A catalyst system can include at least three catalysts. The three catalysts include a metallocene catalyst, a first non-metallocene including a ligand complexed to a metal through two or more nitrogen atoms, and a second non-metallocene including a ligand complexed to a metal through one or more nitrogen atoms and an oxygen atom.

Abstract: The present invention provides an olefin resin with an improved heat resistance, reduced stickiness, excellent optical and low temperature properties, as well as the balance between these physical properties. The olefin resin according to the present invention satisfies the following requirements: (I) a melting peak (Tm) is observed within the range of from 60° C. to 130° C., and the heat of fusion ?H at the melting peak is within the range of from 5 to 150 J/g; (II) the percentage E (wt %) of a portion soluble in o-dichlorobenzene at 20° C. or lower, and the heat of fusion ?H satisfy certain relationships; (III) the glass transition temperature (Tg) is from ?80 to ?30° C.

Abstract: A method of making a partially fluorinated polymer dispersions and resulting aqueous mixtures. The method comprising polymerizing one or more fluorinated monomers in an aqueous emulsion polymerization in the presence of a polymerizable fluorinated emulsifier to form a fluorinated polymer. The polymerizable fluorinated emulsifier has the formula X2C?CX(CF2)m(CH2)n[O—(CX2)p]q-[O—(CX2)r]s—[O—(CX2—CX2)]t—[(O)w—(CX2)u]v-[CH2]z—Y.

Abstract: A copolymer includes a first group that is hydrophobic and a second group that is crosslinkable. Moreover, a glass substrate includes a coating of the copolymer, with interposition of a layer of silane including a functional group capable of reacting with the crosslinkable group. The glass substrate may be used as hydrophobic glazing for a transport vehicle, shower cubicle wall or easy-to-clean interior glazing.

Abstract: A novel amphiphilic graft copolymer is described. A process to make amphiphilic graft copolymers via grafting either poly(ethylene oxide) or polylactide side chains onto an EVA platform using oxo-anion ring-opening polymerization chemistry is also described. Polyethylene or polypropylene based graft copolymers are prepared starting from poly(ethylene-co-vinyl acetate) or maleic anhydride grafted isotactic polypropylene respectively. The amphiphilic character will result from the incorporation of hydrophilic poly(ethylene oxide) (PEO) side-chains. Various applications of the novel amphiphilic graft copolymer are also described including, but not limited to, thermoplastic elastomer, films, fibers, fabrics, gels, breathable packaging materials, additive for biodegradable system, surfactant, antistatic additives, polymer compatibilizers, phase transfer catalysts, solid polymer electrolytes, biocompatible polymers, or incorporation into the materials listed above.

Abstract: Thermoplastic copolymer compositions which contain 50 to 82 wt.-% of a SAN copolymer AI and 15 to 55 wt.-% of a graft copolymer A2, which has an average particle size of 50 to 150 nm and is constituted of at least one rubber-like graft base with a glass transition temperature Tg<0° C., at least one alkyl acrylate, the cyclic cross-linking agent dicyclopentadienyl acrylate and a non-cyclic, additional cross-linking agent, and of 20 to 40 wt.-% of at least one graft shell composed of styrene and acrylonitrile; and auxiliary agents and/or additives, have improved gloss when exposed to weathering.

Abstract: A hollow polymer particle includes a structure body that contains a structure including (1) a core polymer formed by copolymerizing a monomer mixture (a) consisting of 20 to 60% by weight of an acid group-containing monomer and 80 to 40% by weight of another monomer that is copolymerizable with the acid group-containing monomer and (2) a shell polymer formed by copolymerizing a monomer mixture (b) consisting of 0 to 15% by weight of an acid group-containing monomer and 100 to 85% by weight of another monomer that is copolymerizable with the acid group-containing monomer so that the shell polymer substantially surrounding the core polymer. The structure body has at least one void formed by neutralization of at least one portion of an acid group contained in the core polymer. The hollow polymer particle is obtained by adding a preservative during a time period after formation of the core polymer and before formation of the shell polymer.

Abstract: Disclosed are a vinyl chloride based nanocomposite composition and a method of preparing the vinyl chloride based nanocomposite. According to the present invention, a method of preparing a straight vinyl chloride based nanocomposite having a nanomaterial uniformly dispersed therein, by using the vinyl chloride based nanocomposite composition when a vinyl chloride monomer is suspension polymerized in the presence of a protective colloidal agent and a polymerization initiator after preparing a water dispersion suspension using the vinyl chloride based nanocomposite composition based on a hydrophilic composition is provided.

Abstract: The present invention relates to an ampholytic polymeric system obtainable by a process comprising the copolymerization of (i) a monomer according to Formula (1), (ii) an ethylenically unsaturated cationic monomer and (iii) a (co)polymer comprising an ethylenically unsaturated anionic monomer which comprises a sulfonate group: (1) wherein X is O or NR2, R1 and R2 are independently selected from the group consisting of hydrogen and C1-C6 alkyl groups or wherein R1 and R2 form together a (CR1R2)n- chain, wherein n is 3 to 12, and wherein R3 is independently selected from the group consisting of hydrogen and CH3. The present invention further relates to the use of ampholytic polymeric system in separation processes.

Abstract: The present invention relates to new impact modifiers and a process for making these new impact modifiers and their use in polymeric compositions. More particularly the present invention relates to a new polymeric impact modifier with a core-shell structure made by a multistage polymerization process comprising at least one gradient polymer. The present invention relates as well to a process preparing such an impact modifier, especially its recovery process after the end of the polymerization. The present invention also relates to a thermoplastic composition comprising the new impact modifier.

Abstract: A moisture-curable resin composition comprising (a) a moisture-curable polymer having at least one hydrolysable silyl group; (b) a reactive modifier; (c) a catalyst for catalyzing the reaction between the moisture-curable polymer (a) and reactive modifier (b) under curing conditions; and optionally, the composition can contain one or more conventional components, including pigments, fillers, curing catalysts, dyes, plasticizers, thickeners, coupling agents, extenders, volatile organic solvents, wetting agents, tackifiers, crosslinking agents, thermoplastic polymers, ultraviolet stabilizers, and combination thereof. The moisture-curable resin composition is useful in the production of adhesives including hot melt adhesives, primers, sealants and coatings.

Abstract: The invention relates to low-viscosity polymers containing silane groups, the polymers curing rapidly under the effect of moisture to form an elastic material with good heat resistance and being in particular suitable for elastic adhesives and sealants. The polymers containing silane groups are based on special hydoxysilanes which carry a secondary OH group. They are in particular obtained by reacting epoxysilanes with secondary amines.

Abstract: The present invention relates to a temporarily bonded adhesive composition used in wafer manufacturing, to the production method and use thereof. The adhesive composition comprises a component A and a component B, wherein the component A comprises an epoxy resin; and the component B comprises a thiol, an amine and a water soluble polymer.

Abstract: A support material for use in an additive manufacturing system, which compositionally includes a polyglycolic acid polymer, which is at least partially soluble in an aqueous solution, and which is configured for use in the additive manufacturing system for printing a support structure in coordination with printing of a three-dimensional part.

Abstract: Hyper-branched biodegradable polymers are produced by melt processing biodegradable polymers with a branching agent at temperatures that promote free radical reactions between the biodegradable polymer and the branching agent. The biodegradable compositions have an excellent balance of mechanical properties and are suitable for flame retardant applications.

Abstract: A process for preparing a high molecular weight heteraromatic polyester or copolyester is disclosed. A process for preparing a high molecular weight heteroaromatic polyester or copolyester includes the steps of: (a) processing comonomers by mixing together to form a homogeneous solution (1) at least one heteroaromatic dicarboxylic acid having 2-12 carbon atoms or a diester or an acid anhydride derived therefrom, or a mixture thereof; (2) at least one alcohol having 2 to 12 carbon atoms and at least two hydroxyl functionalities; and (3) optionally aromatic or aliphatic dicarboxylic acids or diesters or acid anhydrides derived therefrom; (b) converting the paste/solution obtained in step a) into an esterification product containing at least one diester or at least one oligoester formed from the at least one heteroaromatic dicarboxylic acid and the at least one alcohol; and (c) polycondensing/copolycondensing the reaction product obtained from step b) under reduced pressure.

Abstract: A continuous process for manufacturing a polyester includes introducing reactant components including a terephthalic acid slurry having an ethylene glycol to terephthalic acid molar ratio of about 2 and a TiO2 slurry to an initial reactor vessel and stirring the reactant components at greater than 0 to 200 rpm to form an oligomer; transferring the oligomer, phosphoric acid, and at least one additive (carbon black, 5-sulfoisophthalic acid, 5-sulfoisophthalic acid dimethyl ester, and/or 5-sulfoisophthalic acid diglycolate) to an intermittent reactor vessel and stirring at 400 rpm to 1000 rpm to form an intermediate, wherein the oligomer, the at least one additive, and the phosphoric acid have a residence time of from 1 minute to 5 minutes in the intermittent vessel; and polymerizing the intermediate in a final reactor vessel at a temperature of 285° C. to 320° C., and in the absence of a polyethylene glycol, to obtain the polyester.

Abstract: A meta-substituted trifunctional benzoxazine monomer and compositions containing the same, wherein the trifunctional benzoxazine monomer is represented by the following structure:

Abstract: A cross-linked composition comprises the reaction product of siloxanes having pendant anhydride groups and a reactant having hydroxyl and/or amine functional groups. The cross-linked composition can be of the following general formula (I): (I). Refer to formula (1) Each X can be of the following general formula (i): (i). Refer to formula (i) Each of W and W* is independently an oxygen atom or N—R, with R independently being a hydrogen atom or R1. Each of Y, R3, and R13 is an independently selected divalent group. Each of R1, R11, R4, R14, R5, and R15 is an independently selected substituted or unsubstituted hydrocarbyl group. Each of w and ww, and each of y and yy, is an independently selected integer from 0 to 1,000. Each of x and xx is an independently selected integer from 1 to 100. Typically, w and y are not simultaneously 0, and ww and yy are not simultaneously 0.

Abstract: The invention relates to a method for producing compositions containing vinyl-aromatic copolymers that are obtained in an emulsion polymerization process and comprise production-related salt inclusions. Said compositions are characterized by improved surface quality following storage in a warm-humid environment and are therefore suitable for producing molded articles having a class A surface that remains flawless over time.

Abstract: A method for producing a rubber wet masterbatch includes a solidifying step of mixing a slurry solution containing a filler and a dispersing solvent with a rubber latex solution, and solidifying the resultant mixture to produce a filler-containing rubber solidified product, a dehydrating step of using a first uniaxial extruder to dehydrate the filler-containing rubber solidified product while the solidified product is heated into the range of 100 to 180° C., thereby producing a rubber wet masterbatch, and a drying plasticizing step of using a second uniaxial extruder to plasticize the rubber wet masterbatch while the masterbatch is heated into the range of 120 to 180 C, thereby producing the rubber wet masterbatch further decreased in water content by percentage. The method does not have cooling step between the dehydrating step and the drying plasticizing step.

Abstract: A process for increasing the melt strength of a polyethylene resin comprising a) selecting a polyethylene resin having i) a density, as determined according to ASTM D792, in the range of from 0.865 g/cm3 to 0.97 g/cm3, and ii) a melt index, I2, as determined according to ASTM D1238 (2.16 kg, 190° C.), in the range of from 0.01 g/10 min to 100 g/10 min; b) reacting from 10 ppm to 1000 ppm of at least one peroxide having a 1 hour half-life decomposition temperature from 160° C. to 250° C. with the polyethylene resin under conditions sufficient to increase the melt strength of the polyethylene resin is provided. Also provided are a masterbatch composition and a polymeric composition.

Abstract: A method of making a resin composition comprising; a polyolefin (A); a saponified ethylene-vinyl acetate copolymer (EVOH) (B) having an ethylene content of 20-65 mol % and a degree of saponification of 96% or more; a higher fatty acid metal salt (C) having 8 to 22 carbon atoms; a conjugated polyene compound (D) having a boiling point of 20° C. or higher; an ethylene-vinyl acetate copolymer (E); and a saponified ethylene-vinyl acetate copolymer (F) having an ethylene content of 68-98 mol % and a degree of saponification of 20% or more, wherein the mass ratio (A:B) is 60:40 to 99.9:0.1, the amount of the higher fatty acid metal salts (C) is in the range of 0.0001 to 10 pbm per 100 pbm of the total of the polyolefin (A) and the EVOH (B), the amount of conjugated polyene compound (D) is in the range of 0.000001 to 1 pbm, and the total amount of the ethylene-vinyl acetate copolymer (B) and the saponified ethylene-vinyl acetate copolymer (F) is 0.3 pbm or more.

Abstract: The present invention provides a method for preparing a sample characterized by binding a substance A containing a hydrazide group to a sugar chain and/or a sugar derivative via hydrazone formation between the hydrazide group of the substance A and the reducing end of the sugar chain and/or the sugar derivative thereby to enable the separation and purification of the sugar chain and/or the sugar derivative for an analytical sample from a biological sample containing the sugar chain and/or the sugar derivative by a simple operation.

Abstract: A film includes a vinyl chloride-based resin, a modified epoxidized vegetable oil having a multimer mass content of 5 to 50 %, an aliphatic dibasic acid ester-based compound with not more than 10 carbon atoms having a molecular weight-average of 200 to 1000, and a polyester-based compound having a molecular weight-average of 3000 to 10000, in which a mixture of the modified epoxidized vegetable oil and the aliphatic dibasic acid ester-based compound is compounded in a mass ratio of 30 to 50 parts based on 100 parts of the vinyl chloride-based resin, a content of the modified epoxidized vegetable oil in the mixture of the modified epoxidized vegetable oil and the aliphatic dibasic acid ester-based compound is 30 to 70 % by mass, and the polyester-based compound is compounded in a mass ratio of 5 to 15 parts based on 100 parts of the vinyl chloride-based resin.

Abstract: Disclosed is a method for making polystyrene foam which utilizes one or more atmospheric gases, particularly CO2, as the blowing agent in combination with a polymer processing aid (PPA), typically an ester that is relatively non-volatile at the extrusion temperature range. The blowing agent and the PPA may both be introduced into the molten thermoplastic polystyrene resin or the PPA may be incorporated in the solid source polystyrene resins. The resulting foam will be substantially free of residual blowing agent and dimensionally stable at ambient temperatures.

Abstract: Foams for filling cavities and crevasses and for forming foamed products are provided. The latex foam may include an A-side containing a functionalized latex and a B-side that contains a crosslinking agent and optionally a non-functionalized latex. The A- and/or B-side contain a blowing agent package or components forming the blowing agent package. The blowing agent package may be the combination of two or more chemicals that when mixed together form a gas or a chemical compound that, when activated by heat or light, forms a gas. In an alternate embodiment, the latex foam includes a functionalized latex, an acid, and an encapsulated crosslinking agent and base. Alternatively, the spray latex foam may include a functionalized latex, a crosslinking agent, and an encapsulated dry acid and dry base. The encapsulating agent may be a protective, non-reactive shell that can be broken or melted at the time of application.

Abstract: The combination foam comprises a matrix composed of polyurethane foam and foamed particles of thermoplastic polyurethane comprised therein, where matrix and particles are each made up of polyol components and polyisocyanate components, wherein at least 50% by weight of the basic building blocks forming the polyol component of the matrix and particles are identical and at least 50% by weight of the basic building blocks forming the polyisocyanate component of the matrix and particles are identical.